The ER-induced signalingmechanism coupled with the fact that well over two thirds of breast cancersexhibit high expression of ER, have provided the rationale for preventing andtreating breast cancer by estrogen antagonism, highlighted by the discovery oftamoxifen. Here, ESR1 is linked to breast carcinoma.